Positions

Overview

  • Dr. Danila is an Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). Dr. Danila is an implementation scientist and outcome researcher, passionate about improving the quality, effectiveness and processes/delivery of medical care for patients. Her research program focuses on two main areas: i) the design and evaluation of culturally-adapted and literacy-appropriate health care interventions that improve outcomes for patients with chronic conditions; and ii) the development and implementation of strategies to assist physicians and other health care professionals in engaging in shared decision making and evidence-based clinical practice.

    Dr. Danila is also interested in the redesign of healthcare delivery processes, decreasing healthcare costs and increasing value-based medical care. She has been actively involved as volunteer for the American College of Rheumatology (ACR). She served on the ACR Insurance Subcommittee (ISC) from 2012-2016. She currently serves as a member of the ACR Committee on Quality of Care and as a member of the Alternative Payment Model (APM) Working Group.
  • Selected Publications

    Chapter

    Year Title Altmetric
    2018 Rheumatoid arthritis.  183-199. 2018
    2014 Biology of Normal Joint and Evaluation of the Joint Including CLinical, Imaging, and Pathologic Evaluation.  1912-1919. 2014

    Investigator On

  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • INvestigations In Gout, Hyperuricemia, and ComorbidiTies (INSIGHT) Center of Research Translation (CORT) - Improving Minority Gout Care and Clinical Research Participation in the Southeast  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by GlaxoSmithKline 2018 - 2021
  • Strengthening Translational Research in Diverse Enrollment (STRIDE)  awarded by UNIVERSITY OF MASSACHUSETTS (WORCESTER) 2016 - 2021
  • DNA Sequencing for Newborn Nurseries in the South  awarded by HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY 2017 - 2020
  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease  awarded by Brigham and Women's Hospital 2018 - 2020
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2017 - 2019
  • UAB Multidisciplinary Clinical Research Center (P60)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • UAB Multidisciplinary Clinical Research Center - Project 2: Facilitating Treat-to-Target Using Novel Health Technology with Decision Support  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • UAB Multidisciplinary Clinical Research Center - Project 3  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2019
  • ACE Protocol ARA08: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)  awarded by University of California, San Francisco 2015 - 2019
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2016 - 2019
  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease  awarded by Brigham and Women's Hospital 2018
  • Centers of Research Translation (CoRT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • Patient-Centered Outcomes Research Translation Center  awarded by Baylor University 2016 - 2017
  • Private Grant  awarded by Janssen 2016 - 2017
  • Dissection of the ACPA Response in African-Americans with Rheumatoid Arthritis  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2011 - 2016
  • Private Grant  awarded by ABBVIE INC 2016
  • Private Grant  awarded by UCB, INC. 2012 - 2014
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2012 - 2014
  • Education And Training

  • “Carol Davila” University of Medicine and Pharmacy, Internship
  • Master of Public Health in Epidemiology, University of Alabama at Birmingham 2014
  • Master of Science in Microbiology, University of Victoria 2003
  • Doctor of Medicine, Carol Davila University of Medicine and Pharmacy of Bucharest 1999
  • University of Illinois at Chicago-Advocate Christ Medical Center, Residency 2006
  • UAB Hospital, Postdoctoral Fellowship 2008
  • Full Name

  • Maria Danila